| Name | Title | Contact Details |
|---|
Sequana Medical is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CARE OPTICAL INDUSTRIAL CO is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1934, Beekley Corporation has evolved into the world leading supplier of simple innovative medical products that help imaging, surgical, and radiation therapy professionals save time, improve accuracy, enhance communication and provide a better patient experience. Beekley introduced the X-SPOT, the first ever professional skin marker for diagnostic imaging in 1984. The X-SPOT® replaced a variety of makeshift methods used at the time for communicating an area of concern on film. It quickly became a staple in radiology departments across the country and its quick adaptation in all radiology modalities led Beekley to devote itself to the research and development of simple, low cost, disposable products that would help imaging professionals improve communication, productivity, and patient care. Today, Beekley`s product line has grown to include a broad range of radiologic skin markers, biopsy and patient care devices for Mammography; Breast Biopsy; Radiation Therapy; MRI; CT-Scan and General Radiology.
Behavioral Medicine Associates is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.